This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Thermo Fisher's proposal to acquire Clario Holdings to be reviewed in Australia

( January 20, 2026, 00:38 GMT | Official Statement) -- MLex Summary: The US-based life sciences company Thermo Fisher Scientific’s bid to acquire clinical-trial technology provider Clario Holdings will be reviewed by Australia’s competition regulator. In a statement on Tuesday, the Australian Competition & Consumer Commission said that Thermo Fisher is a global manufacturer and supplier of a broad range of analytical, research and bioprocessing products. The regulator said Clario is a US-based clinical trial technology services company that provides regulatory-grade data capture and interpretation services for clinical trials. The statement added that while Clario provides services to certain customers in Australia, it does not have a legal entity in Australia. The regulator said that Thermo Fisher and Clario provide different types of clinical-trial services to pharmaceutical and biotechnology customers.Statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections